Literature DB >> 24700157

The kidney and lipids: preface.

Bertram Kasiske1, Takao Saito.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24700157     DOI： 10.1007/s10157-014-0954-5

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN： 1342-1751            Impact factor:   2.801


× No keyword cloud information.
  19 in total

1.  Population-based risk assessment of APOL1 on renal disease.

Authors:  David J Friedman; Julia Kozlitina; Giulio Genovese; Prachi Jog; Martin R Pollak
Journal:  J Am Soc Nephrol       Date:  2011-10-13       Impact factor: 10.121

2.  Association of trypanolytic ApoL1 variants with kidney disease in African Americans.

Authors:  Giulio Genovese; David J Friedman; Michael D Ross; Laurence Lecordier; Pierrick Uzureau; Barry I Freedman; Donald W Bowden; Carl D Langefeld; Taras K Oleksyk; Andrea L Uscinski Knob; Andrea J Bernhardy; Pamela J Hicks; George W Nelson; Benoit Vanhollebeke; Cheryl A Winkler; Jeffrey B Kopp; Etienne Pays; Martin R Pollak
Journal:  Science       Date:  2010-07-15       Impact factor: 47.728

Review 3.  Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases.

Authors:  Takao Saito; Akira Matsunaga; Shinichi Oikawa
Journal:  Am J Kidney Dis       Date:  2006-02       Impact factor: 8.860

4.  Intercapillary Lesions in the Glomeruli of the Kidney.

Authors:  P Kimmelstiel; C Wilson
Journal:  Am J Pathol       Date:  1936-01       Impact factor: 4.307

5.  Nephrotic syndrome caused by immune-mediated acquired LCAT deficiency.

Authors:  Satoshi Takahashi; Keiju Hiromura; Mayuko Tsukida; Yuko Ohishi; Hiroko Hamatani; Noriyuki Sakurai; Toru Sakairi; Hidekazu Ikeuchi; Yoriaki Kaneko; Akito Maeshima; Takashi Kuroiwa; Hideaki Yokoo; Takeo Aoki; Michio Nagata; Yoshihisa Nojima
Journal:  J Am Soc Nephrol       Date:  2013-04-25       Impact factor: 10.121

6.  Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

Authors:  Christoph Wanner; Vera Krane; Winfried März; Manfred Olschewski; Johannes F E Mann; Günther Ruf; Eberhard Ritz
Journal:  N Engl J Med       Date:  2005-07-21       Impact factor: 91.245

Review 7.  Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis.

Authors:  Ashish Upadhyay; Amy Earley; Jenny L Lamont; Shana Haynes; Christoph Wanner; Ethan M Balk
Journal:  Ann Intern Med       Date:  2012-08-21       Impact factor: 25.391

8.  Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis?

Authors:  E Muso; M Yashiro; M Matsushima; H Yoshida; K Sawanishi; S Sasayama
Journal:  Nephrol Dial Transplant       Date:  1994       Impact factor: 5.992

9.  Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial.

Authors:  Hallvard Holdaas; Bengt Fellström; Alan G Jardine; Ingar Holme; Gudrun Nyberg; Per Fauchald; Carola Grönhagen-Riska; Søren Madsen; Hans-Hellmut Neumayer; Edward Cole; Bart Maes; Patrice Ambühl; Anders G Olsson; Anders Hartmann; Dag O Solbu; Terje R Pedersen
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

10.  Genetic associations in diabetic nephropathy: a meta-analysis.

Authors:  A L Mooyaart; E J J Valk; L A van Es; J A Bruijn; E de Heer; B I Freedman; O M Dekkers; H J Baelde
Journal:  Diabetologia       Date:  2010-12-03       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.